Apotea (APOTEA) - Total Liabilities
Based on the latest financial reports, Apotea (APOTEA) has total liabilities worth Skr1.28 Billion SEK (≈ $137.77 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Apotea operating cash flow efficiency to assess how effectively this company generates cash.
Apotea - Total Liabilities Trend (2022–2025)
This chart illustrates how Apotea's total liabilities have evolved over time, based on quarterly financial data. Check APOTEA asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Apotea Competitors by Total Liabilities
The table below lists competitors of Apotea ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Akums Drugs and Pharmaceutical
NSE:AKUMS
|
India | Rs19.91 Billion |
|
Celebi Hava Servisi AS
IS:CLEBI
|
Turkey | TL16.76 Billion |
|
WUS Printed Circuit Co Ltd
TW:2316
|
Taiwan | NT$5.69 Billion |
|
Hebei Huijin Electromechanical Co Ltd
SHE:300368
|
China | CN¥289.99 Million |
|
Bain Capital Specialty Finance Inc
NYSE:BCSF
|
USA | $1.51 Billion |
|
Shanghai Baosteel Packaging
SHG:601968
|
China | CN¥5.20 Billion |
|
Neo Performance Materials Inc
TO:NEO
|
Canada | CA$293.88 Million |
|
Double Bond Chemical Ind Co Ltd
TW:4764
|
Taiwan | NT$2.43 Billion |
Liability Composition Analysis (2022–2025)
This chart breaks down Apotea's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see APOTEA stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.35 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.38 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.58 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Apotea's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Apotea (2022–2025)
The table below shows the annual total liabilities of Apotea from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr1.12 Billion ≈ $120.59 Million |
+13.00% |
| 2024-12-31 | Skr991.70 Million ≈ $106.72 Million |
+8.82% |
| 2023-12-31 | Skr911.30 Million ≈ $98.07 Million |
+1.54% |
| 2022-12-31 | Skr897.50 Million ≈ $96.59 Million |
-- |
About Apotea
Apotea AB (publ) operates an online pharmacy in Sweden. The company offers products in the areas of allergy, face, child and parent, bite and sting, preparedness, animal, fever and aches, cold, home and household, aid, hair removal and shaving, hair care, hands and feet, intimate, and dietary supplements. It also provides products in the categories of body care, stomach and intestine, food and dr… Read more